LILI YANG

LILI YANG

University of California, Los Angeles

H-index: 33

North America-United States

About LILI YANG

LILI YANG, With an exceptional h-index of 33 and a recent h-index of 24 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of gene and cell-based immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Does nature-based social prescription improve mental health outcomes? A systematic review and meta-analysis

Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies

Engineering Allorejection-Resistant CAR-NKT Cells from Hematopoietic Stem Cells for Off-The-Shelf Cancer Immunotherapy

416 Profiling ovarian cancer tumor and microenvironment with disease progression for the design of immunotherapy strategies

Graft-versus-Host Disease Modulation by Innate T Cells

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

417 Engineer off-the-shelf NKT cells for cancer immunotherapy

NKT cell: Success and promises in transplantation and immunotherapy

LILI YANG Information

University

Position

Associate Professor of Microbiology Immunology and Molecular Genetics (UCLA)

Citations(all)

5272

Citations(since 2020)

2356

Cited By

3628

hIndex(all)

33

hIndex(since 2020)

24

i10Index(all)

61

i10Index(since 2020)

49

Email

University Profile Page

University of California, Los Angeles

Google Scholar

View Google Scholar Profile

LILI YANG Skills & Research Interests

gene and cell-based immunotherapy

Top articles of LILI YANG

Title

Journal

Author(s)

Publication Date

Does nature-based social prescription improve mental health outcomes? A systematic review and meta-analysis

Rashid Menhas

Lili Yang

Zulkaif Ahmed Saqib

Muhammad Younas

Muhammad Muddasar Saeed

2024/3/25

Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies

Yan-Ruide Li

Tyler Halladay

Lili Yang

2024/1/12

Engineering Allorejection-Resistant CAR-NKT Cells from Hematopoietic Stem Cells for Off-The-Shelf Cancer Immunotherapy

Molecular Therapy

Yan-Ruide Li

Yang Zhou

Jiaji Yu

Yichen Zhu

Derek Lee

...

2024/4/6

416 Profiling ovarian cancer tumor and microenvironment with disease progression for the design of immunotherapy strategies

Yanruide Li

Christopher Ochoa

Lili Yang

2023/11/1

Graft-versus-Host Disease Modulation by Innate T Cells

Ying Fang

Yichen Zhu

Adam Kramer

Yuning Chen

Yan-Ruide Li

...

2023/2/17

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

Yan-Ruide Li

Ying Fang

Zibai Lyu

Yichen Zhu

Lili Yang

2023/10/2

417 Engineer off-the-shelf NKT cells for cancer immunotherapy

Yanruide Li

Lili Yang

2023/11/1

NKT cell: Success and promises in transplantation and immunotherapy

Samuel Zeng

Zhe Li

Derek Lee

Lili Yang

2023/1/1

Synthetic viscoelastic activating cells for T cell engineering and cancer therapy

Song Li

Zeyang Liu

Yan-Ruide Li

Youcheng Yang

Yu Zhu

...

2023/9/15

Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design

Iscience

Yan-Ruide Li

Christopher J Ochoa

Yichen Zhu

Adam Kramer

Matthew Wilson

...

2023/10/20

Advancements in CRISPR screens for the development of cancer immunotherapy strategies

Yan-Ruide Li

Zibai Lyu

Yanxin Tian

Ying Fang

Yichen Zhu

...

2023/12/19

Advancing cell-based cancer immunotherapy through stem cell engineering

Yan-Ruide Li

Zachary Spencer Dunn

Yanqi Yu

Miao Li

Pin Wang

...

2023/5/4

A self-assembled implantable microtubular pacemaker for wireless cardiac electrotherapy

Science Advances

Shaolei Wang

Qingyu Cui

Parinaz Abiri

Mehrdad Roustaei

Enbo Zhu

...

2023/10/18

Monoamine oxidase blockade therapy for treating cancer through regulating antitumor t cell immunity

2023/12/7

Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy

Yuning Chen

Yichen Zhu

Adam Kramer

Ying Fang

Matthew Wilson

...

2023/3/29

Combating covid-19 using engineered inkt cells

2023/10/12

Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering

Nature Communications

Derek Lee

Zachary Spencer Dunn

Wenbin Guo

Carl J Rosenthal

Natalie E Penn

...

2023/11/8

Mucosal-associated invariant T cells for cancer immunotherapy

Yan-Ruide Li

Kuangyi Zhou

Matthew Wilson

Adam Kramer

Yichen Zhu

...

2023/3/1

Community-based social healthcare practices in China for healthy aging: a social prescription perspective analysis

Frontiers in Public Health

Rashid Menhas

Lili Yang

Rana Danish Nisar

2023/10/2

Engineering induced pluripotent stem cells for cancer immunotherapy

Yang Zhou

Miao Li

Kuangyi Zhou

James Brown

Tasha Tsao

...

2022/5/1

See List of Professors in LILI YANG University(University of California, Los Angeles)